LIC Increases Stake in Central Bank of India to 606 Charter Communications Acquires Liberty Broadband in Improved Buyout Deal China Industrial Profits Surge 247 in April Fastest Gain in Over Two Years Despite Economic Headwinds AMD Commits Over 10 Billion to Taiwans AI Ecosystem to Advance NextGeneration Chip Technology Cautiously Optimistic on Indian Markets as Earnings Revival Takes Center Stage Arvind Sanger DR Congo Ebola Suspicion Red Cross Volunteers Deaths Raise Humanitarian and Regional Concerns DHI Group Inc DHX Q1 2026 Earnings Strong EPS Beat Overshadowed by Revenue Concerns YSG Q4 2025 Earnings Strong EPS Performance Lifts Stock Despite Sparse Data CorVel Corp CRVL Q1 2026 Earnings EPS of 061 Reported Stock Edges Higher MAA Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiency LTH Q1 2026 Earnings EPS Surprise Drives Qualified Optimism Despite Weak Stock Reaction Exzeo Group Inc XZO Q1 2026 Earnings EPS Beats Estimates by 521 Stock Edges Higher Allied Gold Corporation AAUC Gains 11 Approaches Resistance at 290 Marathon Petroleum MPC Pushes Higher Testing Key Levels After 25 Gain Resources Connection RGP Declines 35 as Stock Nears Critical 396 Support Level Arqit Quantum Inc Warrants ARQQW Slip Further Testing Critical Floor at 007 uniQure Fades Slightly as 2434 Tests Key Technical Territory President Trump Delays AI Executive Order Citing Concerns Over Potential Obstacles to Innovation Fate Therapeutics Q1 2026 Earnings EPS Beat Drives Stock Uptick Amid Continued Pipeline Progress Gaxosai Inc GXAI Slides 345 as Selling Pressure Tests Key Support Levels LAC Q1 2026 Earnings NarrowerThanExpected Loss Highlights Progress on Thacker Pass AVAV Q1 2026 Earnings EPS Misses Estimates but Stock Rises on Strategic Outlook FNV Q1 2026 Earnings Strong EPS Beat Driven by Higher Streaming and Royalty Revenues Transocean Q1 2026 Earnings Earnings Miss Estimates Amid Challenging Offshore Market ASNS Q1 2026 Earnings Significant EPS Beat Despite Lack of Revenue Disclosure CNM Q1 2026 Earnings EPS Surges 229 Above Estimates Revenue Data Pending Syndax Pharmaceuticals Q1 2026 Earnings Narrowed Loss Beats Estimates as Pipeline Progress Continues